Impact of colchicine on hs-CRP, neutrophil levels, neutrophil-to-lymphocyte ratio and major adverse cardiac events (MACEs) in Thai patients with acute coronary syndrome undergoing percutaneous coronary intervention
Narra J · 11.05.2026 · 6 (2) · e3079
DOI: 10.52225/narra.v6i2.3079 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Narra J, online erschienen am 11.05.2026. Verfasst von Wittawat Wattanasiriporn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Rajavithi Hospital, Bangkok, Thailand. Hauptthemen laut MEDLINE: Colchicine, Acute Coronary Syndrome, Percutaneous Coronary Intervention, C-Reactive Protein. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Acute coronary syndrome (ACS) is strongly associated with inflammation, which contributes to plaque instability, thrombosis, and adverse cardiovascular outcomes. High-sensitivity C-reactive protein (hs-CRP), neutrophil count, and neutrophil-to-lymphocyte ratio (NLR) are inflammatory markers that have been associated with poor prognosis in patients with ACS. Colchicine has emerged as a potential adjunctive anti-inflammatory therapy in cardiovascular disease. This study aimed to evaluate the effects of colchicine on inflammatory markers and clinical outcomes in Thai patients with ACS undergoing percutaneous coronary intervention (PCI). This single-center, retro-prospective observational cohort study included adult patients with ACS who underwent PCI at Rajavithi Hospital, Bangkok, Thailand, in 2024. Patients were classified into colchicine and non-colchicine groups based on treatment exposure after PCI. Hs-CRP, neutrophil count, and NLR were assessed at baseline, 1 month, and 3 months. Major adverse cardiac events (MACE) during follow-up were also recorded. A total of 56 patients were included, comprising 38 in the colchicine group and 18 in the non-colchicine group. Compared with the non-colchicine group, the colchicine group showed significantly greater reductions from baseline to 3 months in hs-CRP levels (2.29±3.37 vs 0.45±1.03; p=0.044), neutrophil count (21.86±10.62 vs 4.13±12.92; p=0.001), and NLR (2.98±2.93 vs 1.68±3.60; p=0.025). No significant differences in MACE were observed between the two groups. This study highlighted that colchicine was associated with greater reductions in inflammatory markers during the early post-PCI period, although no significant difference in short-term clinical outcomes was identified. Larger prospective studies are needed to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Rajavithi Hospital, Bangkok, Thailand.
- Division of Cardiology, Department of Internal Medicine, College of Medicine, Rangsit University, Bangkok, Thailand.
- Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
- Division of Nephrology, Department of Medicine, Rajavithi Hospital, College of medicine, Rangsit University, Bangkok, Thailand.
Zitieren
APA
Wattanasiriporn, W., Rattanasidha, P., Munirwan, H., & Arayangkoon, C. (2026). Impact of colchicine on hs-CRP, neutrophil levels, neutrophil-to-lymphocyte ratio and major adverse cardiac events (MACEs) in Thai patients with acute coronary syndrome undergoing percutaneous coronary intervention. Narra J, 6(2), e3079. https://doi.org/10.52225/narra.v6i2.3079
Vancouver
Wattanasiriporn W, Rattanasidha P, Munirwan H, Arayangkoon C. Impact of colchicine on hs-CRP, neutrophil levels, neutrophil-to-lymphocyte ratio and major adverse cardiac events (MACEs) in Thai patients with acute coronary syndrome undergoing percutaneous coronary intervention. Narra J. 2026;6(2):e3079. doi:10.52225/narra.v6i2.3079
BibTeX
@article{Wattanasiriporn2026,
author = {Wattanasiriporn, Wittawat and Rattanasidha, Paruj and Munirwan, Haris and Arayangkoon, Chantisa},
title = {Impact of colchicine on hs-CRP, neutrophil levels, neutrophil-to-lymphocyte ratio and major adverse cardiac events (MACEs) in Thai patients with acute coronary syndrome undergoing percutaneous coronary intervention},
journal = {Narra J},
year = {2026},
volume = {6},
number = {2},
pages = {e3079},
doi = {10.52225/narra.v6i2.3079}
}
EUVIMED